Mode
Text Size
Log in / Sign up
N/A N=20 Randomized Treatment

Pilot: Digital Therapeutic vs Education for the Management of Problematic Substance Use

Alcohol Use Disorder (AUD) · Substance Use Disorders

Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Feb 2024
Primary outcome: Primary: Change in Number of Substance Use Occasions — -0.6; -7.2; -3.9; -6.7 occasions

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
W-SUDs (Device); Digitally-delivered Psychoeducation (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Woebot Health
Primary completion
May 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Number of Substance Use Occasions
-0.6; -7.2; -3.9; -6.7; -4.9; -6.6
SECONDARY
Past Month Average Days Per Week of Drinking Alcohol
-0.4; -2.4; -0.2; -1.6; -0.6; -1.4
SECONDARY
Past Month Average Standard Drinks in a Day
1.6; -1.0; -0.3; -1.1; -2.4; -0.8
SECONDARY
Past Month Number of Binge Days
4; -1.3; 2.0; -7.4; -3.7; -4.1
SECONDARY
Past Month Average Standard Drinks in a Week
8.2; -8.0; -2.3; -6.7; -10.3; -4.6
SECONDARY
Short Inventory of Problems- Alcohol and Drugs (SIP-AD)
-7.6; -1.1; -7.4; -4.0; -9.6; -4.4
SECONDARY
Craving Ratings
-0.1; 0.0; -0.3; -0.1; -0.3; -0.3
SECONDARY
Working Alliance Inventory (WAI-SR)
0.14; 0.57; 1.57
SECONDARY
Stanford Presenteeism Scale (SPS-6)
2.3; 2.7
SECONDARY
Thoughts About Abstinence (TAA)
-0.8; 1.4; 0.4; -0.8; 0.6; -0.6
SECONDARY
CAIR Pandemic Impact Questionnaire (C-PIQ)
-1.1; 0.1; -2.8; -1.3
SECONDARY
Patient Health Questionnaire (PHQ-8)
-3.9; -2.0; -1.9; -1.2; -1.4; -2.9
SECONDARY
Generalized Anxiety Disorder (GAD-7)
-3.4; 0.6; -0.6; -0.2; -2.7; 0.6
SECONDARY
Brief Situational Confidence Questionnaire (BSCQ)
10.9; 20.7; 10.9; 18.9; 9.2; 20.7
SECONDARY
Usage Rating Profile - Intervention (URPI)-Acceptability
24.1; 27.4
SECONDARY
Usage Rating Profile Intervention - Intervention (URPI)-Feasibility
27.4; 34.2
SECONDARY
Client Satisfaction Questionnaire (CSQ)
23.4; 26.1
SECONDARY
Number of Participants Indicating Substance Use
0; 1; 1; 2; 4; 3
SECONDARY
Number of Participants Providing PEth Sample Phosphatidylethanol (PEth)
5; 5; 3; 4
SECONDARY
Engagement With Control Condition
6.7

Summary

Prior to launching a randomized controlled trial, this pilot study will investigate the feasibility and acceptability of the administration of a diagnostic interview and collection of a biomarker test, as well as engagement and preliminary efficacy with W-SUDs and the education arm, among a sample of adults who screen positive for problematic substance use.

Eligibility Criteria

Inclusion Criteria

  • Have a smartphone
  • Endorse a substance use concern
  • Be between 18 and 65 years of age
  • Be available and committed to engage with the Woebot app
  • Be literate in English.(This is required for inclusion because all materials will be in English).

Exclusion Criteria

  • Pregnancy (as W-SUDs will not be specifically developed to address the unique needs of this population)
  • Suicide attempt within the past year (12 months)
  • Symptoms of severe drug/alcohol history: History of delirium tremens; Experiencing hypertension, drenching sweats, seizures or confusion after stopping alcohol or drugs; Liver trouble (cirrhosis or hepatitis); Convulsions or GI bleeding due to drug/alcohol use
  • Opioid overdose within the past year (12 months)
  • Opioid misuse without medication-assisted treatment
  • Not residing in the U.S.
  • Ever used Woebot
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04974645). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search